50 results
Page 2 of 3
424B3
EX-99.2
oo8d2x9 kfjvrh0
25 Feb 22
Prospectus supplement
8:39am
8-K
EX-99.2
4y312ap60b8hf0
25 Feb 22
Regulation FD Disclosure
8:38am
424B3
q28idv
12 Nov 21
Prospectus supplement
8:41am
8-K
EX-99.1
fmsgnxu03v 3l
13 Aug 21
POINT Biopharma Reports Second Quarter 2021 Financial Results and Provides Business Update
7:00am
424B3
0emwxs6 uj7
5 Aug 21
Prospectus supplement
4:26pm
424B3
9lnl9 9ky
9 Jun 21
Prospectus supplement
4:42pm
8-K
EX-99.1
4wupemp0luj3d0fo4n
4 Jun 21
POINT Biopharma Announces First Patients
4:22pm
425
EX-99.1
95axhti6g58af7u5k
4 Jun 21
Business combination disclosure
4:20pm
CORRESP
7xotlky6vzr8maodzgzw
25 May 21
Correspondence with SEC
12:00am
S-4/A
EX-10.16
0i28rs
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4/A
lp2bjywer4wt8ds
30 Apr 21
Registration of securities issued in business combination transactions (amended)
9:53pm
S-4
EX-10.16
aom1f1g59bfwllulu
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
EX-10.17
azngeono iz
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
S-4
d4g66ueni8yja88bqdhh
22 Mar 21
Registration of securities issued in business combination transactions
9:52pm
8-K/A
EX-2.1
ue101i88h 2q8
18 Mar 21
Financial Statements and Exhibits
9:08am